The high cost of diagnosing and treating cancer—in addition to the prescription drugs and therapies associated with the disease—is bankrupting hard-working Americans, who cannot afford…
Read More
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This could lead to a boom in cancer drugs that can…
